FDA FOIA- Mifepristone Study Contract

  • Oversight Actions
1 min. read

In this FOIA, we sought information from the Food and Drug Administration regarding the solicitation and contract award process for the ongoing mifepristone study. We requested records and communications about the Request for Proposal (RFP), applications, responses, awards, and contracts connected to the mifepristone study and the Sentinel 3.0 program in order to better understand the study’s status and scope.

Submitted: 6/9/2026
30-day response due: 7/23/2026